Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies
Year: 2018
Type: review
Abstract: Over the last 60 years, more than a million patients received hematopoietic cell transplantation. Having incorporated multiple changes in clinical practices, it remains a complex procedure facing a dual challenge: cure of the underlying disease and prevention of relapse while controlling potentially severe complications. Improved understanding of underlying biological processes resulted in the design of innovative therapies engineered from defined cell populations and testing of these therapies as addition or substitution at virtually every step of the procedure. This review provides an overview of these developments, many of them now applied outside the historical field of hematopoietic cell transplantation.
Source: Science Translational Medicine
Institutions: Inserm, Aix-Marseille Université, Institut Paoli-Calmettes, University Medical Center Utrecht, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, King's College London, Policlinico San Matteo Fondazione, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Université Paris Diderot, Ecotaxie, Microenvironnement et développement lymphocytaire, Institut Universitaire d'Hématologie, Hôpital Saint-Antoine, Essen University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G7601770919, G8432524692
OpenAlex ID: W2798148200
